Haku Bio, Inc. funding
Haku Bio, Inc., a biotechnology company based in Arlington, MA (founded 2026), filed a Form D with the SEC on June 10, 2026 and reported $1.3M raised of a $2.5M offering. It filed 2 new offerings in this period, totaling $1.5M.
Amount raised$1.3M
Offering size$2.5M
Filed with the SECJune 10, 2026
First saleMay 22, 2026
IndustryBiotechnology
SecuritiesOther
LocationArlington, MA
Founded2026
Entity typeCorporation
Investors so far5
Minimum investment$100K
Revenue rangeNo Revenues
View the original Form D on SEC EDGAR ↗ · All rounds filed Jun 10
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| June 10, 2026 | $1.3M | $2.5M | Other |
| March 2, 2026 | $210K | Open-ended | Debt |
Other health care rounds in Massachusetts
Zai Lab Ltd$250M · Nov 9BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21BiotechnologyAI3 Bio, Inc.$48.3M · Nov 4BiotechnologyNanopath Inc$29.9M · Nov 13BiotechnologyXRHealth, Inc.$22.8M · Sep 16Other Health CareXact Bio, Inc.$10M · Sep 28BiotechnologyCrosslink Therapeutics Inc.$5.5M · Oct 20PharmaceuticalsFresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care